Document is current
Any future updates will be listed below
-
Authors
Levita, Bogdan https://orcid.org/0009-0009-0603-1186
Eminovic, Semil
Lüdemann, Willie Magnus
Schnapauff, Dirk
Schmidt, Robin
Haack, Anna-Maria
Dell’Orco, Andrea
Nawabi, Jawed
Penzkofer, Tobias
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 11 August 2025
Accepted: 30 September 2025
First Online: 13 October 2025
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare that they have no competing interests.Outside the submitted work, T.P. is funded in part by the Berlin Institute of Health (BIH). T.P. also receives funding from the Berlin Institute of Health (Advanced Clinician Scientist Grant, Platform Grant), Ministry of Education and Research (BMBF, 01KX2021 (RACOON), 01KX2121 (“NUM 2.0”, RACOON), 68GX21001A, 01ZZ2315D), German Research Foundation (DFG, SFB 1340/2), European Union (H2020, CHAIMELEON: 952172, DIGITAL, EUCAIM:101100633). T.P. also declares relationships with the following companies: research agreements (no personal payments) with AGO, Aprea AB, ARCAGY-GINECO, Astellas Pharma Global Inc. (APGD), Astra Zeneca, Clovis Oncology, Inc., Holaira, Incyte Corporation, Karyopharm, Lion Biotechnologies, Inc., MedImmune, Merck Sharp & Dohme Corp, Millennium Pharmaceuticals, Inc., Morphotec Inc., NovoCure Ltd., PharmaMar S.A. and PharmaMar USA, Inc., Roche, Siemens Healthineers, and TESARO Inc., fees for a book translation (Elsevier B.V.), and fees for speaking engagements (Bayer Healthcare). J.N. receives funding from the Berlin Institute of Health (Digital Health Accelerator), the European Union’s Horizon Europe programme (COMFORT, 101079894) and reports personal fees from Eppdata GmbH outside the submitted work.
